PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann
Frechen, Germany
Oncologist in Frechen, North Rhine-Westphalia
Kölner Str. 9, 50226 Frechen
About PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Clinical Trials at PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann
During the past decade, PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
2010-02-22
2015-06-30
Completed
681
A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma
2011-02-15
2017-10-31
Completed
410
A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC)
2015-04-17
2021-03-24
Completed
609
The Effectiveness Of Atezolizumab In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior Chemotherapy
2018-05-30
2023-05-30
Active, not recruiting
359
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann
According to Clinical.Site data, the most researched conditions in "PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann" are
"Colorectal Cancer" (1 trials), "Lymphocytic Leukemia, Chronic" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials) and "Non-Small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann" in a lesser frequency.
Clinical Trials Intervention Types at PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann
Most popular intervention types in "PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "5-FU/LV" (1 trials), "Bevacizumab" (1 trials), "Cetuximab" (1 trials) and "Cobimetinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann
The vast majority of trials in "PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann" are
4 trials for "All" genders.
Clinical Trials Status at PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann
Currently, there are NaN active trials in "PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".